Table 1_Prognosis of second primary oral squamous cell carcinoma after hematologic malignancy: a retrospective cohort analysis.docx

Backgrounds<p>Prognosis and optimal management strategies of second primary oral squamous cell carcinoma (OSCC) following a history of hematologic malignancies (HM) remain uncertain. We investigated whether HM history affects OSCC outcomes or necessitates treatment modifications.</p>Pati...

Full description

Saved in:
Bibliographic Details
Main Author: Huajiao Yu (18554113) (author)
Other Authors: Bo Li (112195) (author), Yu Huang (15093) (author), Xue Zhang (166886) (author), Hanchen Zhou (12527518) (author), Zhien Feng (340611) (author), Zhengxue Han (10684167) (author)
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Backgrounds<p>Prognosis and optimal management strategies of second primary oral squamous cell carcinoma (OSCC) following a history of hematologic malignancies (HM) remain uncertain. We investigated whether HM history affects OSCC outcomes or necessitates treatment modifications.</p>Patients and methods<p>This retrospective cohort study included 2486 OSCC patients: 14 with OSCC as a second primary malignancy post-HM (SPM group) and 2472 with primary OSCC (non-SPM group). Using propensity score matching (PSM), we created two cohorts: 1:17 (13 SPM vs 232 non-SPM) and 1:3 (13 SPM vs 38 non-SPM). Outcomes were disease-free survival (DFS), overall survival (OS), and disease-specific survival (DSS). Survival differences were analyzed using log-rank tests. Multivariate Cox regression identified prognostic predictors.</p>Results<p>No significant survival differences existed between SPM and non-SPM groups in either cohort (1:17: DFS 53.8% vs 68.9%, p=0.102; OS 69.2% vs 81.3%, p=0.170; DSS 69.2% vs 82.2%, p=0.147. 1:3: DFS 53.8% vs 63.2%, p=0.302; OS 69.2% vs 76.3%, p=0.532; DSS 69.2% vs 78.9%, p=0.430). Cox regression identified independent predictors: DFS: Age (p=0.001), T stage (p<0.001), N stage (p<0.001); OS and DSS: Age (p<0.001), T stage (p<0.001), N stage (p<0.001), pathological grade (p<0.001), prior HM was not an independent predictor.</p>Conclusions<p>A history of HM does not independently predict the prognosis of second primary OSCC nor necessitate modifications to standard OSCC treatment.</p>